FIRST TRUST ADVISORS LP

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1125816 Wheaton, IL

Position in CRNX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,370,631

+$505,055 QoQ

Shares Held

63,352

+23.3% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#94

of 266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. CRNX ranks #75 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	547,132	$341,158,687
2	INCY	Incyte Corp	1,587,996	$180,015,226
3	CORT	Corcept Therapeutics Inc	1,829,545	$159,078,937
4	VRTX	Vertex Pharmaceuticals Inc / Ma	289,179	$143,643,884
5	EXEL	Exelixis, Inc.	2,543,353	$138,383,836
6	ALNY	Alnylam Pharmaceuticals, Inc.	421,534	$126,894,380
7	KRYS	Krystal Biotech, Inc.	324,900	$120,755,583
8	AXSM	Axsome Therapeutics, Inc.	482,061	$117,994,070

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,370,631	63,352	+23.3%	Shares	Sole	2026-08-11
2026-03-31	$1,865,576	51,365	+54.9%	Shares	Sole	2026-05-13
2025-12-31	$1,543,132	33,150	+378.3%	Shares	Sole	2026-02-13
2025-09-30	$288,676	6,931	-1.0%	Shares	Sole	2025-11-12
2025-06-30	$201,406	7,003	-81.5%	Shares	Sole	2025-08-13
2025-03-31	$1,266,403	37,758	-80.7%	Shares	Sole	2025-05-14
2024-12-31	$10,012,327	195,821	-6.9%	Shares	Sole	2025-02-13
2024-09-30	$10,750,980	210,391	+6.8%	Shares	Sole	2024-11-13
2024-06-30	$8,821,883	196,961	+93.6%	Shares	Sole	2024-08-13
2024-03-31	$4,762,308	101,737	+38.5%	Shares	Sole	2024-05-13
2023-12-31	$2,613,600	73,457	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.